Rigel Pharmaceuticals Inc.
RIGL | NASDAQ
$47.92
+$0.83 (+1.76%)
Sep 22, 2026, 11:21 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 40.58M | 56.75M | 32.79M | 24.46M | 18.89M | 30.37M |
Short-Term Investments | 114.38M | 20.58M | 24.15M | 33.75M | 106.08M | 26.95M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.91M | 1.44M | 3.06M | 640K | 974K | 824K |
Receivables | 51.76M | 41.62M | 30.55M | 40.32M | 15.47M | 15.97M |
Inventory | 11.51M | 6M | 5.52M | 9.12M | 6.62M | 1.64M |
Other Current Assets | 21.94M | 10.17M | 6.26M | 8.26M | n/a | n/a |
Total Current Assets | 240.17M | 135.1M | 99.27M | 115.9M | 154.47M | 88.98M |
Property-Plant & Equipment | 920K | 338K | 1.03M | 2.79M | 11.89M | 20.57M |
Goodwill & Intangibles | 24.75M | 27.1M | 13.88M | 14.95M | n/a | n/a |
Total Long-Term Assets | 273.43M | 28.87M | 17.96M | 18.38M | 12.86M | 21.4M |
Total Assets | 513.59M | 163.98M | 117.23M | 134.28M | 167.33M | 110.38M |
Account Payables | 7.19M | 3.34M | 7.14M | 22.51M | 3.8M | 3.71M |
Deferred Revenue | 1.36M | 27.8M | 17.04M | 13.51M | 10.51M | 3.02M |
Short-Term Debt | 30.43M | 7.27M | 7.23M | n/a | n/a | n/a |
Other Current Liabilities | 48.35M | 10.14M | 12.32M | 13.86M | 24.2M | 9.59M |
Total Current Liabilities | 99.24M | 63.3M | 53.27M | 65.21M | 63.55M | 40.84M |
Long-Term Debt | 22.48M | 52.41M | 52.37M | 39.45M | 19.91M | 19.82M |
Other Long-Term Liabilities | n/a | 44.98M | 39.94M | 42.26M | 52.73M | 5.05M |
Total Long-Term Liabilities | 22.88M | 97.39M | 92.6M | 82.68M | 73.4M | 35.51M |
Total Liabilities | 122.11M | 160.69M | 145.87M | 147.9M | 136.95M | 76.35M |
Total Debt | 53.3M | 59.97M | 60.58M | 41.55M | 30.57M | 39.09M |
Book Value | 391.48M | 3.29M | -28.64M | -13.62M | 30.37M | 34.03M |
Book Value Per Share | 20.78 | 0.19 | -1.65 | -0.79 | 1.78 | 2.02 |
Common Stock | 18K | 18K | 17K | 174K | 172K | 169K |
Retained Earnings | -1.02B | -1.39B | -1.41B | -1.38B | -1.32B | -1.31B |
Comprehensive Income | 181K | 10K | 8K | -153K | -102K | -4K |
Shareholders Equity | 391.48M | 3.29M | -28.64M | -13.62M | 30.37M | 34.03M |
Total Investments | 114.38M | 20.58M | 24.15M | 33.75M | 106.08M | 26.95M |
Add to Watchlist
Select watchlists to add or remove RIGL